Lexapro for Anxiety: What It Does, How Long It Takes, and What to Expect

No one checks in after they write the prescription. That is the version of anxiety treatment most people have experienced: a medication, a follow-up in six weeks, and a lot of time alone wondering whether something is actually happening.

Lexapro (escitalopram) is one of the most prescribed medications for anxiety in the United States. It is also one of the most misunderstood, not because it is complicated, but because the information people get when they start it rarely matches what the clinical picture actually looks like: a slow build, some turbulence in the first week or two, and then, for most patients, a real reduction in the constant background noise of anxiety.

This is what you need to know before you start, and what to track once you do.

What This Page Covers

• How Lexapro works as an anxiety treatment
• What the FDA approval covers
• Clinical trial results for GAD and other anxiety disorders
• The standard dosing approach
• What to expect in the first weeks
• Common side effects and how to manage them
• Who Lexapro may not be right for
• Stopping Lexapro safely

What Lexapro Is and How It Works

Lexapro is the brand name for escitalopram, a selective serotonin reuptake inhibitor (SSRI). Escitalopram, the (S)-enantiomer of citalopram, is a highly selective serotonin reuptake inhibitor. The FDA recently approved escitalopram for the treatment of generalized anxiety disorder in both adults and children aged 7 and older.

The mechanism is straightforward at the receptor level. Neurons release serotonin into the synapse, where it activates receptors on adjacent neurons. After firing, serotonin is typically recaptured by the releasing neuron through a transporter protein. Lexapro blocks that reuptake transporter, leaving more serotonin available in the synapse for longer.

Over time, this increased serotonin availability produces downstream changes in receptor sensitivity, neuroplasticity, and limbic system regulation that reduce the anxiety response. This is why Lexapro takes weeks to produce full effects: the relevant changes occur at the level of neuroplasticity and gene expression, not at the level of immediate neurotransmitter availability.

Escitalopram is the most receptor-selective SSRI currently available. It also has an allosteric action that distinguishes it from citalopram, its parent compound, and from other SSRIs: it binds both the primary and a secondary allosteric binding site on the serotonin transporter simultaneously, producing a more complete and prolonged blockade.

FDA Approval and Indications

Lexapro is indicated for the acute and maintenance treatment of major depressive disorder in adults and in adolescents 12 to 17 years of age, and for the acute treatment of generalized anxiety disorder (GAD) in adults.

GAD is characterized by excessive, persistent worry and tension that is difficult to control, accompanied by symptoms including restlessness, fatigue, difficulty concentrating, irritability, muscle tension, and sleep disturbance.

Beyond its two FDA-approved indications, escitalopram is widely used off-label for social anxiety disorder, panic disorder, OCD, PTSD, and premenstrual dysphoric disorder. The clinical evidence for these off-label uses is substantial.

What the Clinical Trials Show

Generalized Anxiety Disorder

The FDA approval for GAD was based on three placebo-controlled studies. In each of the three studies, Lexapro 10 to 20 mg per day significantly improved GAD symptoms in patients compared to placebo as measured by change from baseline in Hamilton Anxiety Scale score. By-visit analyses of data pooled across the three studies revealed significantly greater improvement in the Lexapro group beginning at week one or two and continuing through week eight for all primary and secondary efficacy variables.

A randomized trial comparing escitalopram and venlafaxine XR for GAD found both active treatments significantly superior to placebo on secondary efficacy measures, with escitalopram demonstrating better tolerability: discontinuation due to adverse events was not different for escitalopram versus placebo (7 versus 5%), compared to venlafaxine XR where discontinuation was significantly greater than placebo.

Social Anxiety Disorder

Escitalopram is the most selective of the serotonin reuptake inhibitor antidepressants. In a meta-analysis of 1,598 patients from three randomized controlled trials for social anxiety disorder, escitalopram was superior to placebo, with an estimated treatment difference on the Liebowitz Social Anxiety Scale of minus 9.2 points. All doses of escitalopram showed significant superiority in efficacy versus placebo.

A Recent Head-to-Head Study

In a recent randomized controlled trial, mindfulness-based stress reduction (MBSR) and escitalopram were compared in the treatment of anxiety disorders in 276 adults. Both interventions proved effective over 8 weeks. MBSR demonstrated noninferiority to escitalopram in reducing anxiety levels, affirming its potential as an alternative or complementary approach to pharmacotherapy. This finding matters clinically: Lexapro is not uniquely effective, but it is comparably effective to a structured intensive behavioral intervention, and significantly less demanding for many patients to access.

Dosing

The FDA-recommended dosing is straightforward. The recommended starting dose of Lexapro is 10 mg once daily. If the dose is increased to 20 mg, this should occur after a minimum of one week.

Twenty milligrams is the effective ceiling. Doses above 20 mg have not demonstrated additional clinical benefit and carry increased risk of adverse effects including QT interval prolongation, which is a cardiac conduction concern.

For older patients: In two pharmacokinetic studies, escitalopram half-life was increased by approximately 50% in subjects 65 years and older as compared to young subjects. The recommended dosage of Lexapro for elderly patients is 10 mg daily.

For patients with hepatic impairment: the recommended dose is 10 mg daily. The drug is extensively metabolized by the liver, and reduced hepatic function prolongs its effect.

Lexapro is taken once daily. Timing does not significantly affect efficacy, though patients who experience somnolence may prefer evening dosing and those with insomnia may prefer morning dosing.

What to Expect in the First Weeks

Week 1 to 2

The first week is often the hardest. Common early experiences include:

Nausea, particularly if taken on an empty stomach. Taking Lexapro with food reduces but does not eliminate this.

Headache, typically mild and resolving within the first week.

Increased anxiety or jitteriness. This is a recognized early effect with SSRIs and is temporary in most patients. It does not mean the medication is making things worse.

Sleep changes: vivid dreams, changes in sleep architecture, or mild insomnia.

These early side effects reflect the serotonin system adjusting before the longer-term neuroplastic changes take effect. Most resolve by weeks two to four.

Weeks 2 to 4

Initial effects, such as better sleep, appetite, and reduced anxiety, might be seen within the first one to two weeks. During the first week, some people might also experience mild side effects as their body adjusts to the medication. Many patients notice that sleep improves before anxiety does. This is clinically meaningful: improved sleep directly affects anxiety severity the following day.

Reduced physical symptoms of anxiety, including muscle tension, headaches, and gastrointestinal disturbance, often improve before psychological worry does.

Weeks 4 to 8

For GAD and most anxiety disorders, full therapeutic effects typically emerge in this window. It generally takes about four weeks for Lexapro to build up in the system and reach its full effect. For some people, depending on the type of anxiety you have and your age, it can take six to eight weeks or even up to three months to get the full effect of that dose.

A common clinical error is discontinuing Lexapro before adequate time has elapsed. A medication trial is not considered adequate until a therapeutic dose has been maintained for at least four to six weeks.

Side Effects

Common and Typically Temporary

Nausea, headache, diarrhea, dry mouth, and sweating are the most common early side effects. The large majority resolve within two to four weeks.

Increased anxiety in the first one to two weeks is real and predictable. A prescriber who monitors closely during this period can distinguish normal early activation from a medication that is genuinely not working.

Persistent Side Effects

Sexual dysfunction affects approximately 30 to 40% of patients taking escitalopram, including delayed orgasm, decreased libido, and erectile dysfunction. This is the most clinically significant persistent side effect and the leading reason patients discontinue SSRIs.

Use of SSRIs, including Lexapro, may cause symptoms of sexual dysfunction. In male patients, SSRI use may result in ejaculatory delay or failure, decreased libido, and erectile dysfunction. In female patients, SSRI use may result in decreased libido and delayed or absent orgasm. If this becomes problematic, a prescriber can consider dose reduction, timing adjustments, augmentation strategies, or switching to a medication with a lower sexual side effect profile such as bupropion.

Weight changes are modest with escitalopram during short-term use, though long-term SSRI use has been associated with gradual weight gain in some patients.

Discontinuation Syndrome

Symptoms associated with discontinuation of Lexapro and other SSRIs have been reported. A gradual reduction in the dose rather than abrupt cessation is recommended. Discontinuation syndrome is not addiction or dependence; it is the nervous system readjusting. It can be minimized by tapering slowly, always in coordination with your prescriber.

Who Lexapro May Not Be Right For

Lexapro is not appropriate for everyone. Specific considerations:

Concurrent use of MAOIs (monoamine oxidase inhibitors) is contraindicated. A washout period is required when switching between SSRIs and MAOIs.

Patients taking blood thinners, certain migraine medications (triptans), lithium, or other serotonergic agents should discuss interaction risk with their prescriber.

High-dose Lexapro (above 20 mg, which is not recommended) carries a risk of QT prolongation. Patients with known cardiac conduction abnormalities should discuss this with their prescriber.

Lexapro isn’t right for everyone, so it’s important to talk with your doctor before taking Lexapro or any other prescription medication.

About SiggyMD

SiggyMD pairs a clinical AI intake with licensed prescribers for continuous mental health care. Every treatment plan is reviewed and approved by a licensed clinician before anything is prescribed. After treatment starts, daily check-ins track how the medication is working and what side effects are present, so your care team has real data between appointments rather than a quarterly impression.

If you are exploring anxiety treatment options or have been struggling with a medication that has not been adjusted in months, the first step is a conversation. Start your anonymous intake with SiggyMD today and a licensed prescriber will review your clinical picture.

“The most common pattern I see with Lexapro is that patients stop it in the first two weeks because they feel worse,” says Daniel Montville, MD, Psychiatrist, of the SiggyMD clinical team. “That jitteriness in week one is real, but it is not a signal that the medication is wrong. It is a signal that we are in the adjustment window. The patients who get through that window and stay at a therapeutic dose for six weeks are the ones who find out whether it actually works for them.”

What Members Are Saying

SK

S.K., 29

Generalized Anxiety Disorder

“I had tried two other SSRIs before Lexapro. The first two weeks were rough, more anxious than usual and very restless at night. My prescriber told me to expect that. By week four something had shifted. The constant background worry was still there, but it was quieter. By week eight it was manageable in a way it had never been.”

RP

R.P., 45

Social Anxiety Disorder

“I was skeptical because I had read that Lexapro wasn’t FDA-approved for social anxiety. My psychiatrist explained that the evidence is strong even off-label, and that the approval simply hasn’t been sought. I started at 10 mg and was still at 10 mg at three months. It was enough.”

Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary. SiggyMD is currently invite-only.

The Most Important Thing to Know

Anxiety treatment with an SSRI is a process, not an event. The medication needs time, the dose may need adjustment, and side effects in the early weeks are not the same as a reason to stop.

If you want to understand how Lexapro compares to other SSRIs including sertraline, our post on SSRI comparisons covers the clinical tradeoffs across the major options. Or start your intake with SiggyMD to talk with a licensed prescriber about whether Lexapro or a different approach fits your clinical picture.

Sources

1. FDA. Lexapro (escitalopram oxalate) Prescribing Information. Revised 2023.

2. Chu A, Wadhwa R. Escitalopram. In: StatPearls. StatPearls Publishing. Updated 2025.

3. Bose A, et al. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder. Depression and Anxiety. 2008;25(10):854-861.

4. Lader M, et al. Efficacy of escitalopram in the treatment of social anxiety disorder: A meta-analysis versus placebo. European Neuropsychopharmacology. 2016;26(6):1062-1069.

5. Forest Laboratories. Lexapro receives FDA approval for the treatment of generalized anxiety disorder. EurekAlert. December 2003.

6. Allgulander C, et al. Escitalopram for the treatment of GAD: efficacy across different subgroups and outcomes. International Clinical Psychopharmacology. 2005;20(5):273-278.